Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ASP Isotopes (ASPI) EBT (2023 - 2025)

Historic EBT for ASP Isotopes (ASPI) over the last 3 years, with Q3 2025 value amounting to -$12.8 million.

  • ASP Isotopes' EBT fell 7409.55% to -$12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.5 million, marking a year-over-year decrease of 28468.45%. This contributed to the annual value of -$32.3 million for FY2024, which is 9822.56% down from last year.
  • Latest data reveals that ASP Isotopes reported EBT of -$12.8 million as of Q3 2025, which was down 7409.55% from -$75.1 million recorded in Q2 2025.
  • ASP Isotopes' EBT's 5-year high stood at -$3.6 million during Q1 2023, with a 5-year trough of -$75.1 million in Q2 2025.
  • For the 3-year period, ASP Isotopes' EBT averaged around -$13.2 million, with its median value being -$7.4 million (2024).
  • Data for ASP Isotopes' EBT shows a peak YoY increase of 2167.13% (in 2025) and a maximum YoY decrease of 74646.69% (in 2025) over the last 5 years.
  • Over the past 3 years, ASP Isotopes' EBT (Quarter) stood at -$4.2 million in 2023, then tumbled by 117.11% to -$9.1 million in 2024, then crashed by 41.39% to -$12.8 million in 2025.
  • Its EBT was -$12.8 million in Q3 2025, compared to -$75.1 million in Q2 2025 and -$8.5 million in Q1 2025.